Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,693,451 papers from all fields of science
Search
Sign In
Create Free Account
PC-3 cell line
Known as:
PC-3
An adenocarcinoma cell line established in 1979 from a bone metastasis from a 62 year old Caucasian male patient with stage IV prostate carcinoma.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment
S. Müller
,
K. Holzapfel
,
C. Seidl
,
U. Treiber
,
B. Krause
,
R. Senekowitsch-Schmidtke
European Journal of Nuclear Medicine and…
2009
Corpus ID: 11940127
PurposeCholine derivatives labelled with positron emitters are successfully used for PET imaging of prostate cancer patients…
Expand
Highly Cited
2009
Highly Cited
2009
Oleanane Triterpenoid CDDO‐Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro‐survival Akt and mTOR
D. Deeb
,
Xiaohua Gao
,
Hao Jiang
,
S. Dulchavsky
,
S. Gautam
The Prostate
2009
Corpus ID: 206397102
Synthetic triterpenoids are potent anticancer agents, but their therapeutic efficacy or mechanism of action for prostate cancer…
Expand
Highly Cited
2008
Highly Cited
2008
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
D. Nie
,
Yande Guo
,
+7 authors
K. Honn
Cancer Research
2008
Corpus ID: 15977737
Thromboxane A(2) (TxA(2)) is a prostanoid formed by thromboxane synthase using the cyclooxygenase product prostaglandin H(2) as…
Expand
Highly Cited
2007
Highly Cited
2007
P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models
K. Joshi
,
M. Rathos
,
+8 authors
Somesh D. Sharma
Molecular Cancer Therapeutics
2007
Corpus ID: 7586045
P276-00, a flavone that inhibits cyclin-dependent kinases, has been identified by us recently as a novel antineoplastic agent. In…
Expand
Highly Cited
2004
Highly Cited
2004
RRR-α-tocopheryl succinate inhibits human prostate cancer cell invasiveness
Min Zhang
,
S. Altuwaijri
,
S. Yeh
Oncogene
2004
Corpus ID: 32437812
RRR-α-tocopheryl succinate (α-vitamin E succinate, VES), one of the vitamin E derivatives, can effectively inhibit the…
Expand
Highly Cited
2003
Highly Cited
2003
Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
Hongtao Wang
,
A. G. Charles
,
Aaron J Frankel
,
M. Cabot
Urology
2003
Corpus ID: 8350233
Highly Cited
2001
Highly Cited
2001
Voltage‐gated K+ channel activity in human prostate cancer cell lines of markedly different metastatic potential: Distinguishing characteristics of PC‐3 and LNCaP cells
M. Laniado
,
S. P. Fraser
,
M. Djamgoz
The Prostate
2001
Corpus ID: 44689082
Although ion channels are known to contribute to a variety of basic cellular behaviors involved in the metastatic cascade, their…
Expand
Highly Cited
1998
Highly Cited
1998
Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice.
J. Connolly
,
D. Rose
Journal of Urology
1998
Corpus ID: 26167238
Highly Cited
1996
Highly Cited
1996
Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells.
A. Aprikian
,
K. Han
,
S. Chevalier
,
M. Bazinet
,
J. Viallet
Journal of Molecular Endocrinology
1996
Corpus ID: 27850072
Bombesin and gastrin-releasing peptide (GRP) are potent neuropeptides expressed by prostate cancer neuroendocrine cells and are…
Expand
Highly Cited
1991
Highly Cited
1991
Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines.
N. Hoosein
,
D. Boyd
,
W. Hollas
,
A. Mazar
,
J. Henkin
,
L. Chung
Cancer Communications
1991
Corpus ID: 22372425
We have investigated the role of urokinase (UK) and its cell-surface receptor in determining the invasiveness of prostate cancer…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE